Gullik Håkan Wickholm
Direktor/Vorstandsmitglied bei Beactica Therapeutics AB
Aktive Positionen von Gullik Håkan Wickholm
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
| GHW Consulting AB | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Gullik Håkan Wickholm
Ehemalige bekannte Positionen von Gullik Håkan Wickholm
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AstraZeneca AS | Corporate Officer/Principal | - | - |
| GENOVIS AB | Direktor/Vorstandsmitglied | 01.01.2019 | - |
| LYTIX BIOPHARMA | Vorstandsvorsitzender | 01.01.2014 | 07.09.2017 |
| Corporate Officer/Principal | 07.09.2017 | - |
Ausbildung von Gullik Håkan Wickholm
| University of Uppsala | Undergraduate Degree |
Statistik
International
| Schweden | 5 |
| Norwegen | 3 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| GENOVIS AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| AstraZeneca AS | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
| GHW Consulting AB |
- Börse
- Insiders
- Gullik Håkan Wickholm
- Erfahrung
